Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin for Chemotherapy-Induced Anemia
NCT03683810Phase 1Unknown
- Sponsor
- Cyprus University of Technology
- Start
- Jan 2019
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 1, randomised trial (2 arms), sponsored by Cyprus University of Technology. Primary endpoint: Hemoglobin at 12 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT03683810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03683810.